GO:0098985 asymmetric, glutamatergic, excitatory synapse: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0098985 describes a neuron-to-neuron synapse that is asymmetric, uses glutamate as its neurotransmitter, and produces excitatory postsynaptic potentials.
• Asymmetric synapses are ultrastructurally defined by a thick postsynaptic density, which distinguishes them from symmetric inhibitory synapses.
• Glutamatergic excitatory synapses are the primary sites of fast excitatory transmission in the mammalian brain and are essential for learning, memory, and neural circuit function.
• Their formation and maturation depend on trans-synaptic adhesion molecules and scaffolding proteins, including cadherins, neuroligins, and Shank3.
• Disruption of glutamatergic synapse structure or function is linked to neurodevelopmental and neurodegenerative disorders, such as autism spectrum disorder and synucleinopathies.
• Researchers study these synapses using electrophysiology, volume electron microscopy, and genetic models to dissect molecular mechanisms and disease relevance.
Description
The asymmetric, glutamatergic, excitatory synapse (GO:0098985) is a specialized cell-cell junction between neurons that mediates fast excitatory neurotransmission in the central nervous system. It is defined by three key features: an asymmetric ultrastructure with a prominent postsynaptic density, the release of glutamate as the neurotransmitter, and the generation of excitatory postsynaptic potentials in the postsynaptic neuron. This synapse type is the principal substrate for information transfer in the brain and is critical for synaptic plasticity, learning, and memory. Understanding its molecular composition and assembly is therefore a central goal in neuroscience. The term is classified under the cellular component ontology, reflecting its role as a structural and functional entity within neural circuits. Researchers investigate these synapses to uncover mechanisms of brain development, circuit function, and neurological disease.
asymmetric, glutamatergic, excitatory synapse At A Glance
| GO ID | GO:0098985 |
|---|---|
| GO term | asymmetric, glutamatergic, excitatory synapse |
| Ontology | cellular_component |
| Synonym | none |
| Major function | Fast excitatory neurotransmission via glutamate release and postsynaptic depolarization |
| Ultrastructure | Asymmetric junction with a thick postsynaptic density |
| Neurotransmitter | Glutamate |
| Postsynaptic response | Excitatory postsynaptic potential (EPSP) |
| Related disorders | Autism spectrum disorder, synucleinopathies, and other neurological conditions |
What Is GO:0098985?
GO:0098985 defines a neuron-to-neuron synapse that is asymmetric, uses glutamate as its neurotransmitter, and whose activity results in excitatory postsynaptic potentials. The term encompasses the presynaptic terminal, the synaptic cleft, and the postsynaptic specialization, including the postsynaptic density. It is a cellular component term, meaning it describes a specific part of a cell rather than a process or function.
Why Is asymmetric, glutamatergic, excitatory synapse Important in Cell Biology?
Asymmetric, glutamatergic, excitatory synapses are the fundamental units of excitatory communication in the brain, and their dysfunction is implicated in a wide range of neurological and psychiatric disorders. Because they mediate most fast excitatory transmission, they are central to processes such as synaptic plasticity, learning, and memory. Their precise molecular architecture, including the postsynaptic density, is essential for proper signal integration and is a target of intense research.
• They are the primary sites of fast excitatory synaptic transmission in the mammalian brain.
• Their asymmetric structure, with a prominent postsynaptic density, is a hallmark of excitatory synapses.
• They are critical for synaptic plasticity, including long-term potentiation, which underlies learning and memory.
• Disruption of their formation or function is linked to autism spectrum disorders and other neurodevelopmental conditions.
• They are vulnerable to neurodegenerative processes, such as alpha-synuclein aggregation in synucleinopathies.
• They are a major focus for understanding neural circuit development and function.
• They serve as targets for therapeutic strategies aimed at modulating excitatory transmission.
• They can be studied with advanced imaging and electrophysiological techniques to reveal structure-function relationships.
Structure and Composition of asymmetric, glutamatergic, excitatory synapse
Presynaptic Terminal and Glutamate Release
In simple terms: The sending side of the synapse releases glutamate to activate the receiving neuron.
The presynaptic terminal of an asymmetric, glutamatergic synapse is specialized for the release of glutamate, which is packaged into synaptic vesicles. Upon arrival of an action potential, vesicles fuse with the presynaptic membrane and release glutamate into the synaptic cleft. This process depends on the coordinated action of SNARE proteins and calcium sensors, although specific molecular details are beyond the scope of this term. The presynaptic active zone is characterized by a dense collection of proteins that facilitate vesicle docking and fusion.
Postsynaptic Density and Asymmetric Ultrastructure
In simple terms: The receiving side has a thick protein-rich area that makes the synapse look asymmetric under a microscope.
The postsynaptic density (PSD) is an electron-dense specialization on the postsynaptic membrane that is thicker than its presynaptic counterpart, giving the synapse its asymmetric appearance. The PSD contains a high concentration of neurotransmitter receptors, scaffolding proteins, and signaling molecules that together ensure efficient signal transduction. This asymmetric ultrastructure is a defining feature of glutamatergic excitatory synapses and distinguishes them from symmetric inhibitory synapses.
Trans-synaptic Adhesion and Synapse Formation
In simple terms: Proteins that span the gap between neurons help them stick together and form a synapse.
Synapse formation requires trans-synaptic adhesion molecules that bridge the presynaptic and postsynaptic membranes. Members of the cadherin superfamily, such as Celsr3, and other adhesion proteins like neuroligins and neurexins, play key roles in glutamatergic synapse formation. These molecules not only physically connect the two sides but also initiate intracellular signaling that recruits scaffolding proteins to the nascent PSD. Disruption of these adhesion systems can lead to altered synaptic structure and function.
Scaffolding Complexes and Receptor Clustering
In simple terms: Scaffold proteins organize receptors and signaling molecules at the synapse.
The postsynaptic density is organized by scaffolding proteins, including PSD-95, Shank, and Homer, which cluster glutamate receptors and link them to downstream signaling pathways. Shank3, in particular, is critical for the structural integrity of glutamatergic synapses, and its deficiency leads to ultrastructural alterations in the PSD. These scaffolds ensure that receptors are properly positioned opposite presynaptic release sites, enabling efficient synaptic transmission.
Glutamate Receptors and Excitatory Signaling
In simple terms: Glutamate receptors on the receiving side detect glutamate and trigger an excitatory signal.
Ionotropic glutamate receptors, such as AMPA and NMDA receptors, mediate the postsynaptic response to glutamate. Upon binding glutamate, these receptors open ion channels, allowing sodium and calcium influx that depolarizes the postsynaptic membrane and produces an excitatory postsynaptic potential. The number and composition of these receptors at the PSD are dynamically regulated and are central to synaptic plasticity.
Key Genes Involved in GO:0098985 asymmetric, glutamatergic, excitatory synapse
The following genes and proteins are key components or regulators of asymmetric, glutamatergic, excitatory synapses, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GRIN1 | NMDA receptor subunit | Mediates excitatory transmission and plasticity; target for neurological studies |
| GRIN2A | NMDA receptor subunit | Modulates receptor properties; linked to neurodevelopmental disorders |
| GRIA1 | AMPA receptor subunit | Primary mediator of fast excitatory transmission |
| DLG4 (PSD-95) | Postsynaptic scaffolding protein | Organizes receptor clustering and signaling complexes |
| SHANK3 | Postsynaptic scaffolding protein | Critical for PSD integrity; mutations linked to autism |
| HOMER1 | Postsynaptic scaffolding protein | Links group I metabotropic glutamate receptors to signaling |
| CELS R3 | Adhesion molecule | Regulates glutamatergic synapse formation |
| VANGL2 | Adhesion molecule | Opposes Celsr3 in synapse formation |
| NLGN1 | Postsynaptic adhesion molecule | Promotes synapse formation and function |
| NRXN1 | Presynaptic adhesion molecule | Binds neuroligins to organize synapses |
| CAMK2A | Calcium/calmodulin-dependent kinase | Key regulator of synaptic plasticity |
| ARC | Activity-regulated cytoskeletal protein | Involved in synaptic plasticity and receptor trafficking |
| BDNF | Neurotrophic factor | Promotes synaptic development and plasticity |
| SNCA | Alpha-synuclein | Aggregation impairs glutamatergic synapse structure |
| ADORA2A | Adenosine A2A receptor | Modulates glutamatergic transmission in striatum |
| GRM5 | Metabotropic glutamate receptor 5 | Modulates excitatory transmission via G-protein signaling |
| SLC17A7 | Vesicular glutamate transporter 1 | Packages glutamate into synaptic vesicles |
| SLC1A2 | Glutamate transporter | Clears glutamate from the synaptic cleft |
How Is asymmetric, glutamatergic, excitatory synapse Regulated?
The formation and function of asymmetric, glutamatergic, excitatory synapses are regulated by activity-dependent signaling pathways, including calcium/calmodulin-dependent kinase II (CaMKII) and neurotrophic factors such as BDNF. Synaptic strength can be modulated by spike-timing-dependent plasticity, which depends on the relative timing of pre- and postsynaptic action potentials. Additionally, trans-synaptic adhesion molecules like Celsr3 and Vangl2 provide opposing signals that control synapse formation. Adenosine A2A receptors also modulate glutamatergic transmission in specific brain regions.
asymmetric, glutamatergic, excitatory synapse and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SHANK3 | Autism spectrum disorder, synaptic ultrastructure abnormalities | Shank3 knockout rat or mouse |
| SNCA | Parkinson's disease, synucleinopathy | Alpha-synuclein aggregation models |
| GRIN2A | Neurodevelopmental disorders with epilepsy | Grin2a point-mutation knock-in mice |
| CELS R3 | Cortical development and synapse formation defects | Celsr3 conditional knockout mice |
| ADORA2A | Striatal dysfunction, modulation of glutamatergic transmission | A2A receptor knockout mice |
Neurodevelopmental Disorders
Alterations in glutamatergic synapse structure and function are associated with neurodevelopmental disorders such as autism spectrum disorder. For example, Shank3-deficient rats exhibit altered synaptic ultrastructure in the prefrontal cortex, providing a model for autism-related synaptic pathology. Mutations in genes encoding synaptic adhesion molecules and scaffolding proteins have been linked to similar phenotypes.
Neurodegenerative Diseases
Excitatory synaptic structural abnormalities are observed in synucleinopathies. Templated aggregation of alpha-synuclein in the basolateral amygdala produces structural changes at glutamatergic synapses, suggesting a role in early synaptic dysfunction in Parkinson's disease and related disorders. These findings highlight the vulnerability of excitatory synapses to neurodegenerative processes.
Synaptic Dysfunction in Other Conditions
Glutamatergic synapse dysfunction has been implicated in a range of neurological and psychiatric conditions, including schizophrenia and epilepsy, although specific mechanisms vary. The adenosine A2A receptor, which modulates glutamatergic transmission, is a potential target in striatal disorders. Understanding the molecular basis of these synapses is essential for developing targeted therapies.
From asymmetric, glutamatergic, excitatory synapse-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of a specific gene in glutamatergic synapse formation? | Knockout cell or animal model |
| How does a disease-associated point mutation affect synaptic function? | Point-mutation knock-in model |
| Where is a synaptic protein localized? | Tagged knock-in (e.g., GFP fusion) |
| What happens when a synaptic protein is overexpressed? | Overexpression cell or animal model |
| Which genes regulate excitatory synapse development? | CRISPR library screening in neurons |
| How does a mutation alter synaptic ultrastructure? | Volume electron microscopy in mutant models |
How to Study the asymmetric, glutamatergic, excitatory synapse Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Postsynaptic currents and potentials | Functional assessment of synaptic transmission |
| Volume electron microscopy | Synaptic ultrastructure and density | Identification of asymmetric synapses |
| Immunohistochemistry | Protein localization and expression | Visualization of synaptic proteins |
| Co-immunoprecipitation | Protein-protein interactions | Identification of postsynaptic density complexes |
| CRISPR knockout | Loss-of-function effects | Determining gene requirement for synapse formation |
| CRISPR knock-in | Tagged or mutant protein expression | Tracking synaptic proteins in vivo |
| RNA sequencing | Transcriptional changes | Profiling gene expression in synaptic models |
Electrophysiology
Patch-clamp recordings and extracellular field potential recordings are used to measure excitatory postsynaptic currents and potentials, providing functional readouts of synaptic transmission and plasticity. These techniques can be combined with genetic manipulations to assess the impact of specific genes on synaptic function.
Volume Electron Microscopy
Volume electron microscopy enables unambiguous identification of asymmetric synapses based on their ultrastructural features, such as the thick postsynaptic density. This method is essential for quantifying synapse number, size, and morphology in healthy and diseased tissue.
Molecular and Biochemical Assays
Western blotting, co-immunoprecipitation, and proteomics can be used to analyze the composition of the postsynaptic density and identify protein-protein interactions. These approaches help define the molecular architecture of glutamatergic synapses.
Genetic and CRISPR-Based Approaches
CRISPR/Cas9 genome editing allows the generation of knockout, knock-in, and point-mutation models to study gene function at glutamatergic synapses. These models are invaluable for linking specific genes to synaptic phenotypes and disease.
How CRISPR Can Be Used to Study GO:0098985 asymmetric, glutamatergic, excitatory synapse
Knockout
CRISPR knockout models are used to delete genes encoding synaptic proteins, such as Shank3 or Celsr3, to determine their requirement for glutamatergic synapse formation and function. These models can be generated in cell lines or animals and analyzed by electrophysiology and imaging.
Point Mutation
Point mutations identified in patients can be introduced into the genome using CRISPR to study their effects on synaptic function. For example, mutations in GRIN2A or other synaptic genes can be modeled to understand disease mechanisms.
Knock-in
Knock-in of tags or reporter genes allows visualization and tracking of endogenous synaptic proteins. This approach can reveal the dynamic localization of proteins like PSD-95 or AMPA receptors at asymmetric synapses.
Overexpression
Overexpression of synaptic proteins using CRISPR activation or transgenic approaches can test gain-of-function effects. For instance, overexpressing alpha-synuclein can mimic synucleinopathy-related synaptic changes.
How EDITGENE Supports asymmetric, glutamatergic, excitatory synapse Research
Researchers studying asymmetric, glutamatergic, excitatory synapse-related genes often need to determine whether a candidate gene is causally involved in synapse formation, function, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for asymmetric, glutamatergic, excitatory synapse research.
Frequently Asked Questions About asymmetric, glutamatergic, excitatory synapse
What is GO:0098985?
GO:0098985 is a Gene Ontology term for an asymmetric, glutamatergic, excitatory synapse, a neuron-to-neuron synapse that uses glutamate and produces excitatory postsynaptic potentials.
What is an asymmetric synapse?
An asymmetric synapse is a type of synapse characterized by a thicker postsynaptic density compared to the presynaptic side, typically associated with excitatory glutamatergic transmission.
What genes are involved in glutamatergic synapse formation?
Key genes include SHANK3, DLG4 (PSD-95), GRIN1, GRIN2A, GRIA1, CELS R3, and NLGN1, among others.
How are asymmetric synapses identified?
They are identified by electron microscopy as junctions with a prominent postsynaptic density and are often confirmed by the presence of glutamate receptors.
What diseases are linked to glutamatergic synapse dysfunction?
Diseases include autism spectrum disorder, Parkinson's disease, and other neurodegenerative and neurodevelopmental conditions.
What is the role of Shank3 at glutamatergic synapses?
Shank3 is a postsynaptic scaffolding protein critical for the structural integrity of the postsynaptic density; its deficiency leads to synaptic ultrastructural abnormalities.
How can CRISPR be used to study glutamatergic synapses?
CRISPR can generate knockout, knock-in, and point-mutation models to dissect gene function in synapse formation and function.
What methods are used to study excitatory synapses?
Common methods include patch-clamp electrophysiology, volume electron microscopy, immunohistochemistry, and molecular assays.
What is the postsynaptic density?
The postsynaptic density is an electron-dense protein complex on the postsynaptic membrane that contains receptors, scaffolds, and signaling molecules.
Why are glutamatergic synapses important for learning and memory?
They mediate fast excitatory transmission and undergo activity-dependent plasticity, such as long-term potentiation, which is a cellular correlate of learning and memory.
Conclusion
The asymmetric, glutamatergic, excitatory synapse (GO:0098985) is a cornerstone of neural circuit function, enabling fast excitatory transmission and synaptic plasticity. Its precise molecular architecture, defined by a prominent postsynaptic density and glutamate receptors, is essential for normal brain function, and its disruption contributes to numerous neurological disorders. Continued research using advanced genetic, imaging, and electrophysiological tools will further illuminate its roles in health and disease.
References
- 1. Bi GQ et al.. 1998. Synaptic modifications in cultured hippocampal neurons: dependence on spike timing, synaptic strength, and postsynaptic cell type.. J Neurosci 18(24):10464-72 PMID: 9852584
- 2. Gcwensa NZ et al.. 2024. Excitatory synaptic structural abnormalities produced by templated aggregation of α-syn in the basolateral amygdala.. Neurobiol Dis 199:106595 PMID: 38972360
- 4. Garner CC et al.. 2002. Molecular mechanisms of CNS synaptogenesis.. Trends Neurosci 25(5):243-51 PMID: 11972960
- 5. Thakar S et al.. 2017. Evidence for opposing roles of Celsr3 and Vangl2 in glutamatergic synapse formation.. Proc Natl Acad Sci U S A 114(4):E610-E618 PMID: 28057866
- 6. Cano-Astorga N et al.. 2024. Unambiguous identification of asymmetric and symmetric synapses using volume electron microscopy.. Front Neuroanat 18:1348032 PMID: 38645671
- 7. Jacot-Descombes S et al.. 2020. Altered synaptic ultrastructure in the prefrontal cortex of Shank3-deficient rats.. Mol Autism 11(1):89 PMID: 33203459
- 8. Rosin DL et al.. 2003. Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function.. Neurology 61(11 Suppl 6):S12-8 PMID: 14663003
